Cryoanalgesia for Postoperative Pain: 2-Year Outcomes

Cryoanalgesia, Postoperative Pain, Thoracic Surgery, Intercostal Nerve Cryoanalgesia, Lung Resection, Chronic Pain, Neuropathic Pain, Pain Management, Opioid Alternatives, Pulmonary Resection, Surgical Outcomes, Postoperative Complications, Clinical Research, non-opioid pain management, pulmonary resection, chronic postoperative pain, intercostal nerve injury, opioid alternatives for pain management, long-term surgical outcomes, thoracic surgery complications

Key findings at a glance: A study followed 261 patients who received intraoperative cryoanalgesia during lung resection. Approximately 64% reported…

Pediatric Stroke Burden Remains High Despite Falling Mortality

Brain Development Research Offers Clues to Autism

SARS-CoV-2, COVID-19, rhinovirus, common cold, pediatric COVID, HEROS study, interferon response, respiratory viruses, viral interference, immune priming, National Jewish Health, COVID protection, children immunity, respiratory infections, non-invasive research

Study Reveals Cold May Impact SARS-CoV-2 Infection Rates

The Unexpected Protective Role of Rhinoviruses in COVID-19 A groundbreaking study from National Jewish Health.

COVID-19

Heart, Lung, & Brain Risks Persist in COVID-19 Survivors

A French nationwide study reveals that individuals hospitalized with COVID-19 remain at an increased risk.

vaccines

How COVID-19 and Vaccines Differ in Heart Inflammation

A team of international researchers led by the Max Delbrück Center for Molecular Medicine in.

Long Covid

Long COVID: Extended Paxlovid Treatment Offers Hope

A new case series by UC San Francisco (UCSF) suggests that an extended course of.

Trending

Cryoanalgesia for Postoperative Pain: 2-Year Outcomes

Cryoanalgesia, Postoperative Pain, Thoracic Surgery, Intercostal Nerve Cryoanalgesia, Lung Resection, Chronic Pain, Neuropathic Pain, Pain Management, Opioid Alternatives, Pulmonary Resection, Surgical Outcomes, Postoperative Complications, Clinical Research, non-opioid pain management, pulmonary resection, chronic postoperative pain, intercostal nerve injury, opioid alternatives for pain management, long-term surgical outcomes, thoracic surgery complications

Key findings at a glance: A study followed 261 patients who received intraoperative cryoanalgesia during lung resection. Approximately 64% reported…

COVID-19

SARS-CoV-2, COVID-19, rhinovirus, common cold, pediatric COVID, HEROS study, interferon response, respiratory viruses, viral interference, immune priming, National Jewish Health, COVID protection, children immunity, respiratory infections, non-invasive research

Study Reveals Cold May Impact SARS-CoV-2 Infection Rates

The Unexpected Protective Role of Rhinoviruses in COVID-19 A groundbreaking study from National Jewish Health has revealed an intriguing phenomenon:…

Heart, Lung, & Brain Risks Persist in COVID-19 Survivors

A French nationwide study reveals that individuals hospitalized with COVID-19 remain at an increased risk of death and organ-related complications…

How COVID-19 and Vaccines Differ in Heart Inflammation

A team of international researchers led by the Max Delbrück Center for Molecular Medicine in Berlin has identified distinct immune…

Health and Wellness

Smoking, Loneliness, Smoking Cessation, Social Isolation, Psychosocial Health, Tobacco Use, Respiratory Medicine, Public Health, Older Adults, Tobacco Addiction, Smoking and Social Isolation, European Respiratory Society, Preventive Medicine, Behavioral Health, Healthcare Professionals, smoking-related health effects, smoking cessation support, effects of smoking, respiratory health, public health, smoking and mental health

Smoking and Loneliness Linked in Large European Study

Key points: A Europe-wide study of more than 50,000 adults found that current smokers reported greater loneliness than non-smokers. Smokers…

Women’s Healthcare Advances Through FemTech

Key Summary FemTech has grown from menstrual tracking and fertility apps into a major women's healthcare technology sector. The industry…

Mazdutide Shows Significant Weight Loss in Phase 3 Trial

Key Summary Mazdutide, a dual GLP-1 and glucagon receptor agonist, achieved 16.65% mean weight loss in adults with obesity. 84.3%…